Results 121 to 130 of about 274,125 (232)

Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy

International Journal of Women's Health, 2009
SA Kingsberg¹, S Kellogg², M Krychman³1University Hospitals Case Medical Center, Case Western Reserve University Cleveland OH, USA; 2The Pelvic and Sexual Health Institute of Philadelphia, Drexel University College of Medicine,
SA Kingsberg, S Kellogg, M Krychman
doaj  

Non–invasive vulvovaginal rejuvenation: A review [PDF]

Background: Non–invasive vulvovaginal rejuvenation is a promising option for women who want to restore the appearance and function of the vagina. Vaginal atrophy and vulvovaginal laxity are caused by several circumstances, including ageing, menopause ...
Dhillon, Jesryn, Jusuf, Nelva Karmila
core   +2 more sources

An Overview of Vulvovaginal Atrophy‑Related Sexual Dysfunction in Postmenopausal Women [PDF]

, 2015
Menopause and the climacteric period are associated with adverse risk factors for the development of vulvovaginal atrophyrelated sexual dysfunction.
Agu, PU, Ezenyeaku, CCT, Ikeako, LC, Okeke, TC   +3 more
core   +1 more source

The Effect of the CO2 Fractional Laser or Premarin Vaginal Cream on Improving Sexual Function in Menopausal Women: A Randomized Controlled Trial [PDF]

, 2020
Introduction:Sexual dysfunction is a complex problem in postmenopausal women with a prevalence rate of 68 - 86 %. This study aimed to evaluate the effect of a fractional CO2 laser or vaginal cream on the improvement of sexual function in menopausal women.
Eftekhar, Tahereh, Forooghifar, Tahereh, Haghollahi, Fedyeh, Khalili, Tahereh, shariat, Mamak   +4 more
core  

Safety and Efficacy of an Oxytocin Gel and an Equivalent Gel but Without Hormonal Ingredients (Vagivital® Gel) in Postmenopausal Women with Symptoms of Vulvovaginal Atrophy: A Randomized, Double-Blind Controlled Study

Medical Devices: Evidence and Research, 2020
Aino Fianu Jonasson,1 Marie Bixo,2 Inger Sundström Poromaa,3 Mikael Åstrom4 1Department of Clinical Sciences, Intervention and Technology, Division of Obstetrics and Gynecology, Karolinska Institute, Stockholm, Sweden; 2Department of Clinical ...
Fianu Jonasson A, Bixo M, Sundström Poromaa I, Åstrom M   +3 more
doaj  

Efficacy and safety of ultra-low-dose Vagifem (10 mcg)

Patient Preference and Adherence, 2011
Janet A Chollet1,2 1Beth Israel Deaconess Medical Center, Boston, MA, USA; 2Pear Tree Pharmaceuticals, Waltham, MA, USA Abstract: Vulvovaginal atrophy [VVA] is defined as inflammation of the vaginal epithelium due to atrophy secondary to decreased levels
Chollet JA
doaj  

The impact of rehabilitation on the quality of life of patients with vulvovaginal atrophy

Obstetrics Gynecology and Reproduction
Aim: to evaluate the impact of rehabilitation on various components of quality of life (QoL) in patients with vulvovaginal atrophy (VVA).Materials and Methods.
D. M. Ampilogova, A. Solopova, D. Blinov, G. K. Bykovshchenko, S. Khlopkova, A. Ivanov   +5 more
semanticscholar   +1 more source

The effects of a real‐time temperature monitoring non‐ablative monopolar radiofrequency technology on vulvovaginal atrophy symptoms in postmenopausal Chinese women

Journal of Cosmetic Dermatology
Vulvovaginal atrophy (VVA) includes a wide range of conditions affecting the reproductive and urinary systems, often requiring careful evaluation and management for optimal health.
Vivian Cheng, William Tai Chi‐Shing, A. Lee, Rita Lee   +3 more
semanticscholar   +1 more source

Vaginal LASER and estrogen comparison in Genitourinary Syndrome of Menopause

Continence
Aim:: This study aims to compare the efficacy of CO2 fractionated laser therapy and topical estrogen treatment in managing Genitourinary Syndrome of Menopause (GSM).
Aytaj Jafarzade, Aydan Biri, Osman Ufuk Ekiz, Tamer Mungan   +3 more
doaj   +1 more source

Dyspareunia in women in preand postmenopausal period [PDF]

Гинекология, 2016
The article presents current views on the multiple pathogenetic mechanisms of development of dyspareunia in women in pre - and postmenopausal women with positions of biopsychosocial approach.
A I Fedorova
doaj